BURNABY, BC,
Jan. 2, 2014 /CNW/ - Welichem Biotech
Inc. (the "Company") (TSX-V: WBI), announced today that
Ryan B. Zeng has been appointed as a
new director of the Company effective immediately.
Mr. Zeng has been serving as a senior manager of
T&T Supermarket in Richmond, British Columbia since 2008. He has
extensive experience and knowledge in computer sciences, company
operation and management from various industries including
technology and supermarket companies over more than 15 years.
Mr. Zeng obtained his Bachelors Degree in Computer Science from
Jilin University (China) in 1998.
The Company also announced today that Mr.
James Dai has resigned as a director
of the Company effective January 2,
2014. The Company has valued the contribution of Mr.
Dai as a director of the Company and Chair of the Audit Committee
over the past year and wishes his success in his future
endeavors.
About Welichem Biotech Inc.
Welichem Biotech Inc. is a publicly-traded
biotechnology company developing therapeutic drugs in the fields of
autoimmune diseases and cancer. For a more complete business and
financial profile of the Company, interested parties are encouraged
to visit the Company's website, www.welichem.com.
The TSX Venture Exchange has not reviewed and
does not accept responsibility for the adequacy or accuracy of the
content of this news release. This press release contains
forward-looking statements that include our belief as to the
potential of our products. Certain risks and uncertainties such as
our ability to successfully commercialize the products could cause
the Company's actual results to differ materially from those in the
forward-looking statements.
SOURCE Welichem Biotech Inc.